Towards Universal Chemosensory Testing

迈向通用化学感应测试

基本信息

批准号：
10683613
负责人：
MARK W ALBERS
金额：
$ 4万
依托单位：
MONELL CHEMICAL SENSES CENTER
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-04-01 至 2024-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10683613
关键词：
Affect Age Years Ageusia Anosmia Area Attention COVID-19 COVID-19 pandemic Caregivers Chemicals Child Care Communication Communities Consensus Diagnosis Diet and Nutrition Disease Economic Burden Education Environment Environmental Hazards Environmental Risk Factor Facebook Family Fire - disasters Food Friends Functional disorder Gases General Population General Practitioners Goals Guidelines Health Health Personnel Health Professional Healthcare Hearing Human Individual Industry Infection Injury Institution Insurance Intervention Journals Language Lead Letters Licensing Longevity Mainstreaming Medical Methods Minority Modeling Monitor National Health and Nutrition Examination Survey National Institute on Deafness and Other Communication Disorders Neurodegenerative Disorders Nurses Nutritional Olfaction Disorders Otolaryngologist Outcome Paper Participant Patients Peer Review Persons Population Prevalence Public Health Publishing Quality of life Recommendation Reporting Role Safety Science Scientist Sensory Sensory Disorders Signal Transduction Smell Perception Smoke Speed Strategic Planning Surveys Symptoms Taste Disorders Taste Perception Testing Therapeutic Time Translations Twitter Update Vision Work academic review clinical application cost effective experience hazard improved interest live stream outreach positive mood predictive marker programs prospective public education research clinical testing screening screening program social media social relationships specific biomarkers symposium virtual web site

项目摘要

PROJECT SUMMARY The COVID-19 pandemic has brought smell and taste dysfunction to mainstream attention. Despite its role in signaling disease, as well as safety, attachment, and quality of life, the diagnosis of chemosensory disorders is far from accessible for most patients or routinely employed by most health care providers. Aligned with the goals of the 2022-2027 draft of the NIDCD Strategic Plan, we propose a conference to bring together scientists, clinicians, public health officials, patients and all other interested parties to identify opportunities and challenges for implementing routine chemosensory testing nationwide. The organization and execution of the conference result from a collaborative effort of four leaders with diverse backgrounds in the science and clinical application of chemosensory testing who represent institutions with distinct expertise in these areas. Participants in this conference will (i) share state-of-the-art methods in chemosensory testing; (ii) identify benefits and practicalities of chemosensory screening both for individuals and at the population level; (iii) communicate this information to medical associations, health care professionals, academic institutions, governmental agencies, insurance companies, industry, and the general public; and (iv) produce a peer- reviewed, consensus white paper for universal chemosensory testing detailing the rationale and recommendations that emerge from the conference, including a strategy to produce guidelines modeled on other successful campaigns. This in-person conference will include virtual components and childcare assistance, thus enabling the wider participation of diverse groups. We will also make videos of the presentations available online and generate Plain Language materials for the lay public, with both Spanish and English, as outreach content. Together, these activities will advance the use of chemosensory testing in multiple contexts, to speed diagnosis of chemosensory disorders and associated health problems, facilitate therapeutic and supportive interventions for affected individuals, and improve human health and quality of life.

项目概要 COVID-19 大流行使嗅觉和味觉功能障碍引起了主流关注。尽管它的作用信号疾病，以及安全性、依恋和生活质量，化学感应障碍的诊断是大多数患者无法获得或大多数医疗保健提供者常规使用。与为了实现 NIDCD 战略计划 2022-2027 年草案的目标，我们建议召开一次会议，汇集科学家、临床医生、公共卫生官员、患者和所有其他有关各方寻找机会并在全国范围内实施常规化学感应检测面临的挑战。二、本次活动的组织与实施会议是四位具有不同科学和临床背景的领导人共同努力的结果化学感应测试的应用代表了在这些领域具有独特专业知识的机构。本次会议的参与者将（i）分享化学感应测试的最先进方法； (二) 确定化学感应筛查对个人和人群水平的好处和实用性； (三) 将此信息传达给医学协会、医疗保健专业人员、学术机构，政府机构、保险公司、行业和公众； (iv) 产生一个同行经审查的通用化学感应测试的共识白皮书，详细说明了基本原理和会议提出的建议，包括制定指导方针的战略其他成功的活动。这次面对面的会议将包括虚拟部分和儿童保育援助，从而使不同群体更广泛地参与。我们还将制作视频在线提供演示文稿，并为非专业公众生成简单语言材料，包括西班牙语和英语，作为外展内容。这些活动将共同推动化学感应测试在多种背景，以加快化学感应障碍和相关健康问题的诊断，促进为受影响的个人提供治疗和支持性干预措施，并改善人类健康和生活质量。